questionText: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the proposed reform of Medicines and Healthcare products Regulatory Agency statutory fees on investment in the UK market by medical technology companies in the (a) short and (b) long term.
answerText: The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices, and blood components for transfusion in the United Kingdom.Most of the MHRA’s income comes from charging fees for its services. Its fees are set to recove...
heading: Medicines and Healthcare Products Regulatory Agency: Fees and Charges